deltatrials
Recruiting PHASE3 INTERVENTIONAL 2-arm NCT04642027

PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy (PERYTON)

PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy of Biochemical Failure After Radical Prostatectomy for Prostate Cancer

Sponsor: Dutch Cancer Society

Updated 8 times since 2020 Last updated: Feb 26, 2024 Started: Sep 1, 2020 Primary completion: Sep 1, 2029 Completion: Sep 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Cancer Recurrence and Prostate Cancer, this trial is actively recruiting participants. The trial is conducted by Dutch Cancer Society and has accumulated 8 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotRecruiting~Sep 2021 – ~May 2022 · 8 months · monthly snapshotRecruiting~May 2022 – ~Mar 2024 · 22 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotRecruiting~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  4. Mar 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

  5. May 2022 — Mar 2024 [monthly]

    Recruiting PHASE3

Show 3 earlier versions
  1. Sep 2021 — May 2022 [monthly]

    Recruiting PHASE3

  2. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE3

  3. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

    First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dutch Cancer Society
  • University Medical Center Groningen
Data source: University Medical Center Groningen

For direct contact, visit the study record on ClinicalTrials.gov .